Analyst Price Target is $1.35
▲ +588.25% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Ortho Regenerative Technologies in the last 3 months. The average price target is $1.35, with a high forecast of $1.35 and a low forecast of $1.35. The average price target represents a 588.25% upside from the last price of $0.20.
Current Consensus is
The current consensus among 1 investment analysts is to buy stock in Ortho Regenerative Technologies.
Ortho Regenerative Technologies Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.